Younger women with triple negative breast cancer tend to have a worse outcome than older women. In particular, age younger than 40 years at diagnosis is a significant unfavorable prognostic factor among women with triple negative breast cancer, independent of lymph node status, tumor size and use of chemotherapy.
The use of chemotherapy tends to be very limited in older women. However, one study found that, despite not having received adjuvant chemotherapy, older triple negative women had outcomes similar to younger patients, almost half of whom had received chemotherapy. Another study of women at least 70 years old found that radiation treatment after lumpectomy significantly reduces breast cancer mortality in women older than 70 with Stage I, estrogen receptor negative (ER-) tumors. Radiation treatment is currently underutilized in older women.
Below under Selected breast cancer studies are links to studies concerning the influence of age at diagnosis on triple negative breast cancer prognosis.
Food for Breast Cancer triple negative breast cancer articles
Below are links to all of the other articles concerning triple negative breast cancer.
What should triple negative breast cancer patients and survivors eat?
Latest research concerning triple negative breast cancer prognosis
Prognosis of triple negative breast cancer compared to other breast cancer subtypes
Patterns of recurrence in triple negative breast cancer patients
Tumor characteristics influencing prognosis of triple negative breast cancer
Prognosis of African Americans and Latinas with triple negative breast cancer
Influence of BMI, metabolic syndrome and diabetes on triple negative breast cancer prognosis
To see all of the articles, news stories and studies concerning triple negative breast cancer, click on the tripleNegative tag in the list of tags directly below.